MENU
SLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
SELLAS Life Sciences Group (SLS) Ownership - Who owns SELLAS Life Sciences Group?
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
119.01M
P/E Ratio
N/A
Total Cash
13.89M
Projected Growth
N/A
Total Debt
1M
Revenue
N/A
Risk (Beta)
3.11
Dividend Yield
N/A
Total Cash/Share
0.15
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SLS
Capitalization
119M
P/E Ratio
N/A
Risk (Beta)
3.11
Dividend Yield
N/A
Total Cash
13.9M
Total Cash/Share
0.15
Total Debt
1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.47M
P/B Ratio
12.58
Cash Flow
N/A
Earnings
-0.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
1.72
Current Revenue Per Employee
90909.09
Dividends Per Share - Security
N/A
EBITDA
-31.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.00
Revenue To Assets
-240.78
Shares Held By Institutions
10.1M
Shares Outstanding - Current
90.8M
Total Liabilities
9.97M
Total Volume MTD
N/A
Value
-1
Gain YTD
25.962
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com